miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer

Published:2014-09-17 Issue:5 Volume:16 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Tan Xiaohui,Peng Jin,Fu Yebo,An Shejuan,Rezaei Katayoon,Tabbara Sana,Teal Christine B,Man Yan-gao,Brem Rachel F,Fu Sidney W

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-014-0435-5.pdf

Reference39 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.

2. Boyle P: Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol. 2012, 23: vi7-vi12. 10.1093/annonc/mds187.

3. Crown J, O'Shaughnessy J, Gullo G: Emerging targeted therapies in triple-negative breast cancer. Ann Oncol. 2012, 23: vi56-vi65. 10.1093/annonc/mds196.

4. Sharma S, Kelly TK, Jones PA: Epigenetics in cancer. Carcinogenesis. 2010, 31: 27-36. 10.1093/carcin/bgp220.

5. Turner N, Tutt A, Ashworth A: Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer. 2004, 4: 814-819. 10.1038/nrc1457.

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The regulation of microRNAs on chemoresistance in triple-negative breast cancer: a recent update;Epigenomics;2024-04-19

2. miRNAs in the prognosis of triple-negative breast cancer: A review;Life Sciences;2023-11

3. CircNCOR1 regulates breast cancer radiotherapy efficacy by regulating CDK2 via hsa-miR-638 binding;Cellular Signalling;2023-09

4. Prospectives of mirna gene signaling pathway in triple-negative breast cancer;Pathology - Research and Practice;2023-08

5. Functional impact of non-coding RNAs in high-grade breast carcinoma: Moving from resistance to clinical applications: A comprehensive review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3